purpose-built apps do not outperform generic ChatGPT
Meta-analyses consistently indicate that mental health chatbots alleviate symptoms of both anxiety and depression. Although an effect size hovering around 0.3 remains modest within this academic field, it is nonetheless tangible. The core issue surfaces upon reviewing individual clinical trials one by one. Specifically, when a specialized therapy application was pitted against standard ChatGPT, the dedicated app failed to surpass the generic bot across any evaluated metric. Meanwhile, a six-week study tracking 540 participants revealed that the artificial intelligence variant boosted interaction frequency by 2.4 times and engagement duration by 3.8 times, yielding symptom reduction comparable to traditional static workbooks.…